FDA's new authority on drug shortages.
نویسنده
چکیده
Drug companies may be required to report shortages sooner, but the FDA legislation still lacks power.
منابع مشابه
Investigational new drugs: export requirements for unapproved new drug products. Final rule.
The Food and Drug Administration (FDA) is amending its regulations on the exportation of investigational new drugs, including biological products. The final rule describes four different mechanisms for exporting an investigational new drug product. These provisions implement changes in FDA's export authority resulting from the FDA Export Reform and Enhancement Act of 1996 and also simplify the ...
متن کاملClinical trials and the drug review process.
would like to express my appreciation to the I American College of Chest Physicians for inviting me to join you here today, to discuss certain issues bearing on the Food and Drug Administration and its performance. Certainly, we have many things to discuss. For example, of all I heard about the so-called 'drug lag" when I was in Washington, I heard most about beclomethasone and the apparent slo...
متن کاملThe FDA may not regulate tobacco products as "drugs" or as "medical devices".
Professor Richard Merrill contends that the Federal Food, Drug, and Cosmetic Act does not grant the FDA regulatory authority over cigarettes and smokeless tobacco products. The fact that Congress did not expressly deny the FDA regulatory authority over tobacco cannot, Professor Merrill argues, be used to infer such authority. This inference is particularly inappropriate in the case of tobacco...
متن کاملAn evaluation of the FDA's analysis of the costs and benefits of the graphic warning label regulation
The Family Smoking Prevention and Tobacco Control Act of 2009 gave the Food and Drug Administration (FDA) regulatory authority over cigarettes and smokeless tobacco products and authorised it to assert jurisdiction over other tobacco products. As with other Federal agencies, FDA is required to assess the costs and benefits of its significant regulatory actions. To date, FDA has issued economic ...
متن کاملFDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
On December 14, 2006, the Food and Drug Administration (FDA) proposed two new regulations in the Federal Register amending current regulations governing expanded access to investigational drugs for treatment use and charging for investigational drugs. The proposals come at a time when FDA has found itself under new pressure to provide seriously ill patients with early access to investigational ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- P & T : a peer-reviewed journal for formulary management
دوره 37 7 شماره
صفحات -
تاریخ انتشار 2012